Literature DB >> 11778242

[The number of lymph node with metastases influences survival in patients with cancer of the thoracic esophagus].

Y Xu1, Z Guo.   

Abstract

OBJECTIVE: To study the extent of lymph node involvement in relation to survival of patients with thoracic esophageal carcinoma.
METHODS: From 1990 to 1993, there were 112 patients with thoracic esophageal carcinoma undergone esophagectomy through right thoracotomy and three-field lymphadenectomy. They were classified into three groups: group A, 44 patients without lymph node involvement; group B, 36 patients with 1 to 3 positive nodes; group C, 32 patients with > or = 4 involved lymph nodes. Nine possible factors influencing survival were studied. A multivariate analysis of these variables was performed using the cumulative survival rate by the computer's Cox proportional hazard model.
RESULTS: The over-all cumulative survival rate was 58.4% at 5 years. That for patients in group A, B and C was 88.4%, 50.8% and 20.8%, respectively. Apart from the extent of lymph node metastases, depth of tumor invasion, location and differentiation of tumor were of prognostic significance.
CONCLUSION: Lymph node metastasis is the major factor affecting survival of patients with cancer of the thoracic esophagus.

Entities:  

Mesh:

Year:  2000        PMID: 11778242

Source DB:  PubMed          Journal:  Zhonghua Zhong Liu Za Zhi        ISSN: 0253-3766


  2 in total

1.  Mast cell density and the context of clinicopathological parameters and expression of p185, estrogen receptor, and proliferating cell nuclear antigen in gastric carcinoma.

Authors:  Ying-An Jiang; You-Yuan Zhang; He-Sheng Luo; Shou-Fu Xing
Journal:  World J Gastroenterol       Date:  2002-12       Impact factor: 5.742

2.  The N-classification for esophageal cancer staging: should it be based on number, distance, or extent of the lymph node metastasis?

Authors:  Qi-Rong Xu; Xue-Peng Zhuge; He-Lin Zhang; Yu-Min Ping; Long-Qi Chen
Journal:  World J Surg       Date:  2011-06       Impact factor: 3.352

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.